Redox Ltd (FRA:AE0)
€ 2.28 +0.020 (+0.88%) Market Cap: 1.23 Bil Enterprise Value: 1.22 Bil PE Ratio: 25.16 PB Ratio: 3.67 GF Score: 70/100

Half Year 2026 Redox Ltd Earnings Call Transcript

Feb 19, 2026 / 12:00AM GMT
Release Date Price: €1.69 (+9.74%)

Key Points

Positve
  • Redox Ltd (ASX:RDX) achieved a sales growth of 6.6% to $674 million, driven by acquisitions and strong performance in industrial and food segments, particularly in North America.
  • Gross profit increased by 5.9% to $145 million, with resilient gross profit margins at 21.5%, showcasing strong cost discipline.
  • The company maintained a healthy net cash position of $145 million with zero net debt, providing significant capital for strategic M&A opportunities.
  • Proforma earnings per share rose by 8.9% against the previous corresponding period, reflecting strong financial performance.
  • The board declared an interim dividend of 6.5% per share, maintaining a payout ratio within the target range of 60% to 80% of NPAT.
Negative
  • The human health and nutrition segment experienced a decline due to softened demand in New Zealand.
  • Underlying operating expenses increased by $6 million to $85.8 million, driven by volume-related expenses and higher administration costs.
  • The company faces challenges with tariffs in the USA, complicating competitive positioning and customer ordering behavior.
  • Despite a strong balance sheet, no recent acquisitions have been completed, partly due to high prices and the need for strategic fit.
  • Market conditions remain dynamic, with subdued global demand impacting overall growth potential.
Raimond Coneliano
Redox Ltd - Chief Executive Officer, Managing Director, Executive Director

Good morning and welcome to our half year 2026 results briefing. I'm Raimond Coneliano, CEO and managing director of Redox Ltd, and presenting with me today is our Chief Financial Officer, Kim Yap.

Moving to slide two. Slide two outlines the agenda for today. I will open the presentation with some performance highlights before passing to Kim to take you through the financials. I'll then come back and ask, add some comments on our strategy and outlook. We'll then be happy to finish by taking some Q&A.

Turning straight to slide four.

Against the subdued global demand backdrop, Redox Ltd delivered sales growth of 6.6% to $674 million against PCP, driven by recently acquired businesses and particularly strong outcomes in our industrial and food segments, as well as North America.

Pleasingly, our gross profit increased 5.9% to $145 million, while gross profit margins remain resilient at 21.5%, which demonstrates the strength of our operating model and cost discipline.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot